Moreover, expression of LMP1 and interferon-gamma activation in NPC cells can induce PD-L1 expression, which is found in up to 95% of NPC tumors and is associated with poorer outcomes but may predict responses to PD-1 inhibitors. Here, PDLIM7 is linked to nasopharyngeal carcinoma.